If another sleeve was to be let go they would have been gone with CCI. Specialty may be moving to another disease state(s) - Alz. Look at the pipeline. It’s all going to be based on all the indications coming out to get the meds into the hands of patients faster with even some pre launch activities it sounds. All new P&Ls for each new unit.
